219 related articles for article (PubMed ID: 28339425)
1. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
[TBL] [Abstract][Full Text] [Related]
2. Activation of the OVOL1-OVOL2 Axis in the Hair Bulb and in Pilomatricoma.
Ito T; Tsuji G; Ohno F; Uchi H; Nakahara T; Hashimoto-Hachiya A; Yoshida Y; Yamamoto O; Oda Y; Furue M
Am J Pathol; 2016 Apr; 186(4):1036-43. PubMed ID: 26873447
[TBL] [Abstract][Full Text] [Related]
3. The role of the OVOL1-OVOL2 axis in normal and diseased human skin.
Tsuji G; Ito T; Chiba T; Mitoma C; Nakahara T; Uchi H; Furue M
J Dermatol Sci; 2018 Jun; 90(3):227-231. PubMed ID: 29454536
[TBL] [Abstract][Full Text] [Related]
4. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
[No Abstract] [Full Text] [Related]
6. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
Hughes JH; Robinson RA
Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
[TBL] [Abstract][Full Text] [Related]
7. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
Wang Q; Ma H; Wang S; Ma Y; Zou X; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1075-7. PubMed ID: 23895857
[TBL] [Abstract][Full Text] [Related]
8. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
10. OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma.
Murata M; Ito T; Tanaka Y; Yamamura K; Furue K; Furue M
J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32106476
[TBL] [Abstract][Full Text] [Related]
11. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease.
Kawakami T; Soma Y; Mizoguchi M; Saito R
Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221
[TBL] [Abstract][Full Text] [Related]
12. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
13. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma.
Jang TJ
Yonsei Med J; 2002 Jun; 43(3):304-8. PubMed ID: 12089736
[TBL] [Abstract][Full Text] [Related]
15. All Bowen's disease is squamous cell carcinoma in situ, but all squamous cell carcinoma in situ is not Bowen's disease.
Martin AA; Hudgins EM; McMullan FH
J Cutan Pathol; 2010 Nov; 37(11):1186-7. PubMed ID: 20579212
[No Abstract] [Full Text] [Related]
16. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of transforming growth factor-beta3 immunohistochemical staining in extramammary Paget's disease, but downregulated expression in Bowen's disease.
Kawakami T; Soma Y; Mizoguchi M; Saito R
Int J Dermatol; 2001 Apr; 40(4):262-7. PubMed ID: 11454082
[TBL] [Abstract][Full Text] [Related]
18. Nestin expression in Bowen's disease and Bowen's carcinoma associated with human papillomavirus.
Mii S; Amoh Y; Tanabe K; Kitasato H; Sato Y; Katsuoka K
Eur J Dermatol; 2011; 21(4):515-9. PubMed ID: 21700534
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
Tanese K; Emoto K; Kubota N; Fukuma M; Sakamoto M
J Dermatol; 2018 Oct; 45(10):1181-1186. PubMed ID: 30035333
[TBL] [Abstract][Full Text] [Related]
20. Expression of p63 and cyclooxygenase-2 and their correlation in skin tumors.
Wu Y; Liu H; Li J
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):206-8. PubMed ID: 17497299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
